Falco Holdings CoTSE:4671 -0.39%71 Net Margin % is 5.44% as of Dec. 2025, which is 34% above its 10-year median of 4.06. GuruFocus rates TSE:4671 with a GF Score™ of 71/100 and a GF Value™ of 円2,528.99 (Fairly Valued). The stock has 6 warning signs investors should review. Among 204 Medical Diagnostics & Research companies, Falco Holdings Co ranks better than 63.73% on this metric.
The historical rank and industry rank for Falco Holdings Co's Net Margin % or its related term are showing as below:
TSE:4671'
s Net Margin % Range Over the Past 10 Years
Min: 1.48 Med: 4.06 Max: 7.07
Current: 4.63
TSE:4671's Net Margin % is ranked better than 63.73% of 204
companies
in the Medical Diagnostics & Research industry
Industry Median: -2.405
vs TSE:4671: 4.63
Falco Holdings Co (TSE:4671) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Falco Holdings Co Net Margin % Related Terms
Falco Holdings Co Net Margin % Historical Data
* Premium members only.
The historical data trend for Falco Holdings Co's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:4671 vs TMO, DHR, IDXX: Net Margin % Comparison
For the Diagnostics & Research subindustry, Falco Holdings Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Falco Holdings Co Net Margin % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Falco Holdings Co's Net Margin % distribution charts can be found below:
* The bar in red indicates where Falco Holdings Co's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Falco Holdings Co (TSE:4671) has a Net Margin % of 5.44% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on Falco Holdings Co and its competitors. This is 34% above median its historical median of 4.06. Over the past decade, Falco Holdings Co's Net Margin % has ranged from 1.48 to 7.07. According to the industry distribution chart, Falco Holdings Co ranks #74 out of 204 companies in the Medical Diagnostics & Research industry, placing it in the top 36.3%.
Is Falco Holdings Co's Net Margin % too high?
Falco Holdings Co's current Net Margin % of 5.44% is 34% above median its 10-year median of 4.06. Over the past 10 years, this metric has ranged from a low of 1.48 to a high of 7.07. Based on the distribution chart, Falco Holdings Co ranks #74 out of 204 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Falco Holdings Co has a GF Score™ of 71/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Falco Holdings Co's Net Margin % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Falco Holdings Co ranks #74 out of 204 companies for Net Margin %. This puts Falco Holdings Co in the upper half of its industry. Historically, Falco Holdings Co's own Net Margin % has ranged from 1.48 to 7.07 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Diagnostics & Research company?
A good Net Margin % depends on the Medical Diagnostics & Research industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Falco Holdings Co and its competitors. Falco Holdings Co's current Net Margin % is 5.44%, which is 34% above median its own 10-year median of 4.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Falco Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Falco Holdings Co (TSE:4671) is currently considered Fairly Valued. The stock's GF Value™ is 円2,528.99, compared to a current price of 円2,544.00 — trading 0.6% above its estimated fair value. The current Net Margin % is 5.44%, which is 34% above median its 10-year median of 4.06. Falco Holdings Co's overall GF Score™ is 71/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Falco Holdings Co (TSE:4671), the current Net Margin % is 5.44% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Falco Holdings Co (TSE:4671) Overvalued in 2026?
Based on GuruFocus' analysis, Falco Holdings Co stock appears to be overvalued.
The current stock price of 円2,544.00 is trading 0.6% above its estimated GF Value™ of 円2,528.99.
GuruFocus considers Falco Holdings Co to be Fairly Valued.
Key valuation signals for TSE:4671:
Net Margin %: 5.44% (34% above median its 10-year median of 4.06)
GF Value™: 円2,528.99 vs. price of 円2,544.00 (0.6% above fair value)
No single metric tells the full story. See the TSE:4671 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Falco Holdings Co Ltd provides testing services. The company is engaged in providing clinical testing and genetic testing services, testing in clinical research and clinical trials, food sanitation, and environmental testing, and pharmacy business. It also engaged in providing information technology business.
71GF Score
Get the complete analysis for TSE:4671
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4671 has been successfully added to your 
